Current Report Filing (8-k)
September 02 2022 - 08:44AM
Edgar (US Regulatory)
0000818479false00008184792022-09-012022-09-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of
1934
September 2, 2022 (September 1, 2022)
Date of Report (Date of earliest event reported)
DENTSPLY SIRONA Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
0-16211 |
39-1434669
|
|
|
(State or other jurisdiction of incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
13320 Ballantyne Corporate Place,
|
Charlotte
|
North Carolina
|
28277-3607
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
(844)
848-0137
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
|
Common Stock, par value $0.01 per share |
XRAY |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
o
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On September 1, 2022, DENTSPLY SIRONA Inc. (the “Company”) and
Walter Petersohn, the Company’s Senior Vice President, Chief
Commercial Officer, mutually agreed upon the separation of Mr.
Petersohn from the Company, effective September 30, 2022 (the
“Termination Date”).
From September 1, 2022, until the Termination Date, Mr. Petersohn
will be an inactive employee but is expected to remain available
for executive transition requests.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Company has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
DENTSPLY
SIRONA Inc.
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Cherée H. Johnson
|
|
|
Cherée H. Johnson |
|
|
Senior Vice President - Chief Legal |
|
|
Officer, General Counsel and Secretary |
|
Date: September 2, 2022
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Jan 2023 to Feb 2023
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Feb 2022 to Feb 2023
